Laryngeal Mask Ambu Aura Once vs. Supreme in Children
Launched by MEDICAL UNIVERSITY INNSBRUCK · Oct 30, 2012
Trial Information
Current as of May 14, 2025
Withdrawn
Keywords
ClinConnect Summary
Before starting surgery patients will be anesthetised and airway managed either with LMA Ambu AuraOnce or Supreme. Ventilation parameters, stomach inflation, and hemodynamic parameters will be measured.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Children aged 1-10 years
- • ASA I - III
- • Elective procedure in general anaesthesia
- • Parental informed consent
- Exclusion Criteria:
- • Non fasting patient
- • Body mass index \> 35 kg/m2
- • Cervical spine pathologies or peripheral neurologic deficiences
- • Malformations of upper airway or head
- • Anamnestic hiatus hernia or esophageal reflux
- • Status post operation of stomach or esophagus
- • Recurrent respiratory infection or obstructive airway disease
- • Non elective procedure
About Medical University Innsbruck
The Medical University of Innsbruck is a leading academic institution dedicated to advancing healthcare through innovative research and clinical excellence. Situated in the heart of the Austrian Alps, it combines a rich tradition of medical education with cutting-edge scientific inquiry. As a prominent sponsor of clinical trials, the university focuses on a broad spectrum of medical fields, emphasizing the translation of research findings into practical applications for patient care. With a commitment to ethical standards and rigorous methodologies, the Medical University of Innsbruck strives to enhance treatment options and improve health outcomes globally through its collaborative efforts in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Innsbruck, Tirol, Austria
Patients applied
Trial Officials
Peter Paal, MD,DESA,EDIC
Principal Investigator
University Hospital Innsbruck, Department of Anaesthesia + Intensive Care
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials